Gynecomastia (Male Chest) | Gynecomastia in Teenagers and Young Adults

In published clinical literature, physiologic gynecomastia follows a trimodal distribution peaking in newborns, adolescents, and older men. During puberty, typical onset occurs at 13 to 14 years of age, or Tanner stage 3 or 4. It is driven by a temporary hormonal shift involving an increase in estradiol concentration, lagging free testosterone production, and heightened breast tissue sensitivity to normal male estrogen levels. Nonphysiologic enlargement can also occur from substances, supplements, medications, or underlying disorders. Medical evidence notes that adolescent physiologic gynecomastia usually resolves within six months to two years, though clinical evaluation is indicated if enlargement persists after two years or past 17 years of age.

During puberty, fluctuating estrogen and testosterone activity can temporarily stimulate glandular breast tissue, causing transient, tender enlargement. While spontaneous regression is frequent as hormones stabilize, swelling persisting past one year or age 17 often undergoes glandular fibrosis, making natural resolution unlikely. Dr. Vishal Purohit does not prescribe medications for gynecomastia, noting that pubertal gynecomastia does not need medicine. When enlargement fails to resolve naturally and produces substantial distress, surgical excision combined with liposuction is evaluated. For teenagers, Dr. Purohit performs corrective surgery only at least two years after puberty is complete.

Gynecomastia is benign enlargement of male breast tissue resulting from the proliferation of glandular ductal and stromal components alongside variable adipose deposition, representing the most prevalent male breast pathology. In published reports, the condition affects an estimated 32% to 65% of the global male population. While benign, associated psychological and physical morbidity can be substantial, frequently inducing body dysmorphia, anxiety, and impaired physical functioning in adolescent and young adult cohorts. In teenagers, Dr. Vishal Purohit advises waiting at least two years after puberty is complete before undertaking surgery. Diagnostic evaluation prioritizes clinical examination and direct palpation, with imaging such as ultrasound or MRI utilized selectively.

Adolescent breast enlargement frequently develops due to normal hormonal changes during sexual maturation. Operating too early during active puberty carries the risk of glandular regrowth or unnecessary surgery, as pubertal tissue often regresses spontaneously. For this reason, Dr. Vishal Purohit requires that male patients wait at least two years after completing puberty before undergoing surgical intervention. Candidacy also requires that the patient's general health remains within tolerable limits for anaesthesia and proper surgical healing. When surgery is indicated after this stabilization period, a dual-modality approach combining circumferential liposuction with sharp periareolar gland excision is performed to achieve a contoured chest.

Gynecomastia refers to male breast enlargement caused by proliferation of glandular ductal, stromal, or fatty tissue. While transient breast enlargement frequently occurs during normal adolescent development, literature indicates that watchful waiting is clinically appropriate initially. Persistent tissue proliferation does not regress spontaneously, often causing psychological suffering and withdrawal. When enlargement persists, surgical management is indicated. For teenagers, Dr. Vishal Purohit considers surgery at least two years after puberty is complete, reserving endocrinologist referral for sudden development well after puberty or associated hormonal symptoms. He combines circumferential liposuction with sharp gland excision through an inconspicuous lower hemi-periareolar incision to restore a masculine chest contour.